A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B

The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status

1992 • 1,071 citations

A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification

1988 • 934 citations

Cytomegalovirus: Biology and Infection.

1983 • 443 citations

Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response

1990 • 316 citations

Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.

1995 • 197 citations

Immune evasion by human cytomegalovirus: lessons in immunology and cell biology

2001 • 124 citations

The Humoral Immune Response against Human Cytomegalovirus Is Characterized by a Delayed Synthesis of Glycoprotein-Specific Antibodies

1997 • 122 citations

Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus

1989 • 119 citations

Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies

1993 • 116 citations

Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies

1992 • 114 citations

Antibody and Virus: Binding and Neutralization

2000 • 111 citations

A Model for Neutralization of Viruses Based on Antibody Coating of the Virion Surface

2001 • 109 citations

Light chain shuffling of a high affinity antibody results in a drift in epitope recognition

1996 • 94 citations

Human cytomegalovirus structural proteins

1994 • 84 citations

Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116)

1992 • 68 citations

Human Monoclonal Antibodies Neutralizing Human Cytomegalovirus

1987 • 63 citations

A recombinant subunit vaccine approach to HCMV vaccine development.

1991 • 61 citations

Humoral immune response to functional regions of human cytomegalovirus glycoprotein B

1997 • 53 citations

Prevention and Treatment of Cytomegalovirus Pneumonia in Transplant Recipients

1993 • 51 citations

Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates

1995 • 46 citations

Neutralizing Mechanisms of Two Human Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein 130/55

1992 • 33 citations

Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection

1996 • 32 citations

Phase I Study on Human Monoclonal Antibody Against Cytomegalovirus

1991 • 29 citations

Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not

2001 • 20 citations

Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations.

1992 • 14 citations

EVALUATION OF NEUTRALIZING ANTIBODY TITERS AGAINST HUMAN CYTOMEGALOVIRUS IN INTRAVENOUS GAMMA GLOBULIN PREPARATIONS

1992 • 12 citations

Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals

1994 • 12 citations

Characterisation, standardisation and control of therapeutic immunoglobulin preparations intended for intravenous use

1987 • 5 citations